Pulmonary Embolism PE Response program (AngioVac Device) Dr. David Zlotnick

Dr. David Zlotnick describes the new generation AngioVac and how this tool is used to remove unwanted intravascular material and is incorporated into a comprehensive Pulmonary Embolism Response Team program.

Innovating Pulmonary Embolism Management: The AngioVac System in Action

Explore the cutting-edge in pulmonary embolism (PE) treatment with our detailed webinar on the Pulmonary Embolism Response Program, featuring Dr. David Zlotnick's insights on the revolutionary AngioVac device. This session provides a comprehensive look into how this device is transforming the approach to managing complex cases of pulmonary embolism, enhancing both safety and efficacy in clinical practice.

Introduction to the AngioVac Device

The AngioVac system is designed as a veno-venous bypass unit without an oxygenator, integrating a unique cannula and filtration system to remove undesirable intravascular material such as thrombi directly from the bloodstream. The device operates by creating a localized vortex flow, safely extracting clots while returning filtered blood back to the patient, thus maintaining hemodynamic stability throughout the procedure.

Clinical Applications and Insights

Dr. Zlotnick delves into the specifics of deploying the AngioVac system, highlighting its flexibility across various scenarios, including:

• Direct Clot Removal: Demonstrated through case studies where the device effectively addresses significant thrombi within cardiac structures.
• Device Versatility: Discusses different configurations and access points, such as femoral or jugular access, adapting to patient-specific anatomical and clinical needs.
• Integration with ECMO: For critically unstable patients, the AngioVac can be integrated with veno-arterial ECMO, providing crucial support while managing acute PE.

Technical Considerations and Operation

The webinar provides an in-depth look at the operational aspects of the AngioVac system:

• Setup and Deployment: Step-by-step guidance on setting up the system, choosing access sites, and deploying the cannula.
• Real-Time Monitoring and Adjustments: Importance of continuous monitoring and adjustments during the procedure to ensure optimal outcomes and avoid complications such as cannula obstruction or displacement.

Advantages Over Traditional Methods

Dr. Zlotnick discusses the advantages of using the AngioVac system over traditional surgical thrombectomy, which includes reduced risk of bleeding, avoidance of general anesthesia in certain cases, and the ability to perform the procedure in a minimally invasive manner, leading to quicker recovery times and less post-operative discomfort for patients.

Collaborative Care Approaches

The presentation emphasizes the importance of a multidisciplinary approach in managing PE, involving interventional cardiologists, perfusionists, and other specialists. This collaborative approach ensures comprehensive patient care, from assessment through to post-procedure recovery.

Future Directions and Research

The session concludes with a discussion on the future potential of the AngioVac system, ongoing research, and the evolution of PE management protocols to incorporate such advanced technologies more broadly.

Conclusion

This webinar is essential for healthcare professionals involved in the management of pulmonary embolism, offering a detailed overview of a novel therapeutic tool that enhances patient outcomes and operational efficiencies. It also serves as an educational platform for those looking to familiarize themselves with the latest advancements in minimally invasive vascular procedures.

 
#perfusion #angiovac #bloodclot
Register and watch for free @ https://library.perfusioneducation.com 
See Our Schedule: https://perfweb.us/webinar-schedule/